ABU DHABI/WAM Mubadala Investment Company PJSC (Mubadala), an Abu Dhabi sovereign investor, and the Abu ...
Read More »Biocon inks deal with Novartis after US nod for biologic drug
Bloomberg Biocon Ltd. said it signed a deal to develop copycat versions of biologic drugs with a unit of Novartis AG, its latest move to become a global player in the next generation of generic medicines after a similar partnership with Mylan NV delivered a recent success. The tie-up with Novartis’s generics unit Sandoz will focus on developing copies, or ...
Read More »